Just a small breather at 0.65c. I believe the annual report is due in about 10 days... hopefully there will be some guidance in that! The waiting game is on for now... key milestones are the approval of patents in India & Hong Kong, the USA FDA approval, then we await the distribution/royalty agreements with the global pathology players. Janssen will likely want to secure a longer term exclusive deal as a complementary diagnostic. Given the persistently low market cap of PIQ a takeover bid is also a possibility, the stock has a very bright future & it is tightly held by management - I would be surprised if a bid were to be accepted.
Ann: PromarkerD Intellectual Property portfolio expands, page-51
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
0.005(0.49%) |
Mkt cap ! $134.2M | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.06 | $1.00 | $134.2K | 131.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3987 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 4762 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |